TickerFacts.

Myriad Genetics Inc (MYGN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$151.60M
Year ended 2022-12-31
$162.47M2009-06-30: $76.52M2010-06-30: $147.19M2011-06-30: $127.04M2012-06-30: $132.40M2013-06-30: $162.47M2016-06-30: $161.30M2017-06-30: $100.10M2018-06-30: $107.50M2019-06-30: $75.10M2020-06-30: $50.50M2021-12-31: $600.0K2022-12-31: -$151.60M-$151.60M
2009-06-30 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$151.60Mn/m2025-02-28, From 2022-01-01
2021-12-31$600.0Kn/a2024-02-28, From 2021-01-01
No annual figure between 2020-06-30 and 2021-12-31.
2020-06-30$50.50M-32.8%2023-03-01, From 2019-07-01
2019-06-30$75.10M-30.1%2022-02-25, From 2018-07-01
2018-06-30$107.50M+7.4%2020-08-13, From 2017-07-01
2017-06-30$100.10M-37.9%2019-08-13, From 2016-07-01
2016-06-30$161.30Mn/a2018-08-24, From 2015-07-01
No annual figure between 2013-06-30 and 2016-06-30.
2013-06-30$162.47M+22.7%2015-08-12, From 2012-07-01
2012-06-30$132.40M+4.2%2014-08-13, From 2011-07-01
2011-06-30$127.04M-13.7%2013-08-14, From 2010-07-01
2010-06-30$147.19M+92.4%2012-08-15, From 2009-07-01
2009-06-30$76.52Mn/a2011-08-15, From 2008-07-01